Zone-specific pathological correlates of PI-RADS 4–5 lesions and the role of multiparametric MRI lesion size in predicting pathological upstaging: A series of radical prostatectomies

Purpose: Using radical retropubic prostatectomy (RRP) specimens as the reference standard, we assessed whether PI-RADS 4–5 lesions in the transitional zone (TZ) and peripheral zone (PZ) differ in their association with clinically significant prostate cancer (csPCa), whether the composition of non-csPCa lesions differs by zone, and whether multiparametric MRI (mpMRI) lesion size predicts pathological upstaging. Materials and methods: Preoperative mpMRI data from 55 patients (108 lesions) undergoing RRP were retrospectively analyzed. A single experienced radiologist scored lesions using PI-RADS v2.1; each was correlated with the specimen by anatomical compartment. PI-RADS 4–5 lesions were classified as (A) csPCa (ISUP Grade Group ⩾ 2), (B) ISUP GG1, or (C) no neoplastic correlate within the corresponding compartment. Upstaging was defined as clinical T2a/T2b to surgical ⩾T2c, or clinical T2c to surgical ⩾T3a. Results: csPCa was identified in 25.9% (7/27) of TZ PI-RADS 4–5 lesions versus 70.0% (35/50) in the PZ ( p < 0.001). Maximum lesion diameter was larger in patients with upstaging (18.7 ± 7.6 vs 11.8 ± 2.8 mm; p = 0.0003); the AUC was 0.808 (95% CI 0.694–0.922) and the Youden-selected cut-off was ⩾13 mm (sensitivity 87.9%, specificity 61.9%, OR = 11.78). After adjustment for age and PSA, lesion size remained the only significant predictor (aOR = 1.294 per mm, p = 0.003), and the association persisted when the endpoint was restricted to extraprostatic extension (per 10 mm: OR = 4.96, 95% CI 1.90–16.92). Among non-csPCa lesions, 11 of 20 in the TZ had no neoplastic correlate versus 1 of 15 in the PZ ( p = 0.004). Conclusion: Larger mpMRI lesion size was associated with pathological upstaging, an association that persisted after adjustment and under a stricter endpoint; the ⩾13 mm threshold is exploratory pending external validation. Most TZ PI-RADS 4–5 lesions were non-csPCa, and lesions lacking a neoplastic correlate were more frequent in the TZ, although this comparison rested on a single such lesion in the PZ and is hypothesis-generating

Authors

Institutions

Publication Details

Journal
Urologia Journal
Published
2026-10-29
DOI
https://doi.org/10.1177/03915603261499067
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Zone-specific pathological correlates of PI-RADS 4–5 lesions and the role of multiparametric MRI lesion size in predicting pathological upstaging: A series of radical prostatectomies

Öner Odabaş, Ahmet Murat Bayraktar, Bilgi İşler
2 links
Urologia Journal
Prostate Cancer Diagnosis and Treatment
article

Zone-specific pathological correlates of PI-RADS 4–5 lesions and the role of multiparametric MRI lesion size in predicting pathological upstaging: A series of radical prostatectomies

Öner Odabaş, Ahmet Murat Bayraktar, Bilgi İşler
article en

Abstract

Purpose: Using radical retropubic prostatectomy (RRP) specimens as the reference standard, we assessed whether PI-RADS 4–5 lesions in the transitional zone (TZ) and peripheral zone (PZ) differ in their association with clinically significant prostate cancer (csPCa), whether the composition of non-csPCa lesions differs by zone, and whether multiparametric MRI (mpMRI) lesion size predicts pathological upstaging. Materials and methods: Preoperative mpMRI data from 55 patients (108 lesions) undergoing RRP were retrospectively analyzed. A single experienced radiologist scored lesions using PI-RADS v2.1; each was correlated with the specimen by anatomical compartment. PI-RADS 4–5 lesions were classified as (A) csPCa (ISUP Grade Group ⩾ 2), (B) ISUP GG1, or (C) no neoplastic correlate within the corresponding compartment. Upstaging was defined as clinical T2a/T2b to surgical ⩾T2c, or clinical T2c to surgical ⩾T3a. Results: csPCa was identified in 25.9% (7/27) of TZ PI-RADS 4–5 lesions versus 70.0% (35/50) in the PZ ( p < 0.001). Maximum lesion diameter was larger in patients with upstaging (18.7 ± 7.6 vs 11.8 ± 2.8 mm; p = 0.0003); the AUC was 0.808 (95% CI 0.694–0.922) and the Youden-selected cut-off was ⩾13 mm (sensitivity 87.9%, specificity 61.9%, OR = 11.78). After adjustment for age and PSA, lesion size remained the only significant predictor (aOR = 1.294 per mm, p = 0.003), and the association persisted when the endpoint was restricted to extraprostatic extension (per 10 mm: OR = 4.96, 95% CI 1.90–16.92). Among non-csPCa lesions, 11 of 20 in the TZ had no neoplastic correlate versus 1 of 15 in the PZ ( p = 0.004). Conclusion: Larger mpMRI lesion size was associated with pathological upstaging, an association that persisted after adjustment and under a stricter endpoint; the ⩾13 mm threshold is exploratory pending external validation. Most TZ PI-RADS 4–5 lesions were non-csPCa, and lesions lacking a neoplastic correlate were more frequent in the TZ, although this comparison rested on a single such lesion in the PZ and is hypothesis-generating

Urologia Journal
Sağlık Bilimleri Üniversitesi (TR), Ankara Bilkent City Hospital (TR), Konya City Hospital (TR)
Good health and well-being
Openalex Percentile: Top 12%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon